229 related articles for article (PubMed ID: 30076898)
1. S100B suppression alters polarization of infiltrating myeloid-derived cells in gliomas and inhibits tumor growth.
Gao H; Zhang IY; Zhang L; Song Y; Liu S; Ren H; Liu H; Zhou H; Su Y; Yang Y; Badie B
Cancer Lett; 2018 Dec; 439():91-100. PubMed ID: 30076898
[TBL] [Abstract][Full Text] [Related]
2. S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages.
Wang H; Zhang L; Zhang IY; Chen X; Da Fonseca A; Wu S; Ren H; Badie S; Sadeghi S; Ouyang M; Warden CD; Badie B
Clin Cancer Res; 2013 Jul; 19(14):3764-75. PubMed ID: 23719262
[TBL] [Abstract][Full Text] [Related]
3. S100B attenuates microglia activation in gliomas: possible role of STAT3 pathway.
Zhang L; Liu W; Alizadeh D; Zhao D; Farrukh O; Lin J; Badie SA; Badie B
Glia; 2011 Mar; 59(3):486-98. PubMed ID: 21264954
[TBL] [Abstract][Full Text] [Related]
4. Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model.
Osterberg N; Ferrara N; Vacher J; Gaedicke S; Niedermann G; Weyerbrock A; Doostkam S; Schaefer HE; Plate KH; Machein MR
Neuro Oncol; 2016 Jul; 18(7):939-49. PubMed ID: 26951383
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
[TBL] [Abstract][Full Text] [Related]
6. The role of S100B in the interaction between adipocytes and macrophages.
Fujiya A; Nagasaki H; Seino Y; Okawa T; Kato J; Fukami A; Himeno T; Uenishi E; Tsunekawa S; Kamiya H; Nakamura J; Oiso Y; Hamada Y
Obesity (Silver Spring); 2014 Feb; 22(2):371-9. PubMed ID: 23804363
[TBL] [Abstract][Full Text] [Related]
7. C6 glioma-conditioned medium induces malignant transformation of mesenchymal stem cells: Possible role of S100B/RAGE pathway.
Tan B; Shen L; Yang K; Huang D; Li X; Li Y; Zhao L; Chen J; Yi Q; Xu H; Tian J; Zhu J
Biochem Biophys Res Commun; 2018 Jan; 495(1):78-85. PubMed ID: 29050939
[TBL] [Abstract][Full Text] [Related]
8. Tumour-derived CSF2/granulocyte macrophage colony stimulating factor controls myeloid cell accumulation and progression of gliomas.
Sielska M; Przanowski P; Pasierbińska M; Wojnicki K; Poleszak K; Wojtas B; Grzeganek D; Ellert-Miklaszewska A; Ku MC; Kettenmann H; Kaminska B
Br J Cancer; 2020 Aug; 123(3):438-448. PubMed ID: 32390004
[TBL] [Abstract][Full Text] [Related]
9. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
[TBL] [Abstract][Full Text] [Related]
10. Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cells.
Hasan MN; Luo L; Ding D; Song S; Bhuiyan MIH; Liu R; Foley LM; Guan X; Kohanbash G; Hitchens TK; Castro MG; Zhang Z; Sun D
Theranostics; 2021; 11(3):1295-1309. PubMed ID: 33391535
[No Abstract] [Full Text] [Related]
11. Characterization of Arginase Expression in Glioma-Associated Microglia and Macrophages.
Zhang I; Alizadeh D; Liang J; Zhang L; Gao H; Song Y; Ren H; Ouyang M; Wu X; D'Apuzzo M; Badie B
PLoS One; 2016; 11(12):e0165118. PubMed ID: 27936099
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin disrupts pathological features of glioma cells and associated macrophages independent of apoptosis induction.
Roberts NB; Alqazzaz A; Hwang JR; Qi X; Keegan AD; Kim AJ; Winkles JA; Woodworth GF
J Neurooncol; 2018 Dec; 140(3):497-507. PubMed ID: 30132163
[TBL] [Abstract][Full Text] [Related]
13. Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma.
McFarland BC; Marks MP; Rowse AL; Fehling SC; Gerigk M; Qin H; Benveniste EN
Oncotarget; 2016 Apr; 7(15):20621-35. PubMed ID: 26967393
[TBL] [Abstract][Full Text] [Related]
14. The controversial role of microglia in malignant gliomas.
Wei J; Gabrusiewicz K; Heimberger A
Clin Dev Immunol; 2013; 2013():285246. PubMed ID: 23983766
[TBL] [Abstract][Full Text] [Related]
15. Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages.
Ochocka N; Segit P; Walentynowicz KA; Wojnicki K; Cyranowski S; Swatler J; Mieczkowski J; Kaminska B
Nat Commun; 2021 Feb; 12(1):1151. PubMed ID: 33608526
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma.
Fujita M; Zhu X; Sasaki K; Ueda R; Low KL; Pollack IF; Okada H
J Immunol; 2008 Feb; 180(4):2089-98. PubMed ID: 18250414
[TBL] [Abstract][Full Text] [Related]
17. The effect of serotonin-noradrenaline reuptake inhibitor duloxetine on the intervertebral disk-related radiculopathy in rats.
Handa J; Sekiguchi M; Krupkova O; Konno S
Eur Spine J; 2016 Mar; 25(3):877-87. PubMed ID: 26394856
[TBL] [Abstract][Full Text] [Related]
18. Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy.
Zhu X; Fujita M; Snyder LA; Okada H
J Neurooncol; 2011 Aug; 104(1):83-92. PubMed ID: 21116835
[TBL] [Abstract][Full Text] [Related]
19. Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization.
Barberi T; Martin A; Suresh R; Barakat DJ; Harris-Bookman S; Drake CG; Lim M; Friedman AD
Cancer Immunol Immunother; 2018 Oct; 67(10):1491-1503. PubMed ID: 30030559
[TBL] [Abstract][Full Text] [Related]
20. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
